212 related articles for article (PubMed ID: 8703577)
21. The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism.
Kaji H; Yamauchi M; Chihara K; Sugimoto T
Eur J Endocrinol; 2005 Sep; 153(3):373-8. PubMed ID: 16131599
[TBL] [Abstract][Full Text] [Related]
22. The impact of serum FSH and estradiol on postmenopausal osteoporosis related to time since menopause.
Yoldemir T; Erenus M; Durmusoglu F
Gynecol Endocrinol; 2012 Nov; 28(11):884-8. PubMed ID: 22731753
[TBL] [Abstract][Full Text] [Related]
23. Lumbar bone mineral density in very long-term renal transplant recipients: impact of circulating sex hormones.
Brandenburg VM; Ketteler M; Heussen N; Politt D; Frank RD; Westenfeld R; Ittel TH; Floege J
Osteoporos Int; 2005 Dec; 16(12):1611-20. PubMed ID: 15999293
[TBL] [Abstract][Full Text] [Related]
24. [Number of teeth and hormonal profile of postmenopausal women with osteoporosis, osteopenia and normal bone mineral density--a preliminary study].
Stagraczyński M; Kulczyk T; Leszczyński P; Męczekalski B
Pol Merkur Lekarski; 2015 Oct; 39(232):214-8. PubMed ID: 26608487
[TBL] [Abstract][Full Text] [Related]
25. Bone mineral density and hormone levels in menopausal Australian women.
Guthrie JR; Ebeling PR; Hopper JL; Dennerstein L; Wark JD; Burger HG
Gynecol Endocrinol; 1996 Jun; 10(3):199-205. PubMed ID: 8862496
[TBL] [Abstract][Full Text] [Related]
26. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
Uretmen S; Gol M; Cimrin D; Irmak E
Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
[TBL] [Abstract][Full Text] [Related]
27. Association of serum undercarboxylated osteocalcin with serum estradiol in pre-, peri- and early post-menopausal women.
Yasui T; Uemura H; Tomita J; Miyatani Y; Yamada M; Miura M; Irahara M
J Endocrinol Invest; 2006 Nov; 29(10):913-8. PubMed ID: 17185901
[TBL] [Abstract][Full Text] [Related]
28. A placebo-controlled, single-blind study to determine the appropriate alendronate dosage in postmenopausal Japanese patients with osteoporosis. The Alendronate Research Group.
Shiraki M; Kushida K; Fukunaga M; Kishimoto H; Kaneda K; Minaguchi H; Inoue T; Tomita A; Nagata Y; Nakashima M; Orimo H
Endocr J; 1998 Apr; 45(2):191-201. PubMed ID: 9700472
[TBL] [Abstract][Full Text] [Related]
29. Metabolic markers for the early diagnosis of postmenopausal osteoporosis.
Isaia G; Mussetta M; Di Stefano M; Sciolla A; Triolo S; Molinatti GM
J Endocrinol Invest; 1994 Nov; 17(10):771-4. PubMed ID: 7699209
[TBL] [Abstract][Full Text] [Related]
30. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN.
Sowers MR; Finkelstein JS; Ettinger B; Bondarenko I; Neer RM; Cauley JA; Sherman S; Greendale GA;
Osteoporos Int; 2003 Jan; 14(1):44-52. PubMed ID: 12577184
[TBL] [Abstract][Full Text] [Related]
31. Effects of the combined use of calcitonin and 1 alpha-hydroxycholecalciferol on vertebral bone loss and bone turnover in women with postmenopausal osteopenia and osteoporosis: a prospective study of long-term and continuous administration with low dose calcitonin.
Ushiroyama T; Ikeda A; Sakai M; Higashiyama T; Ueki M
Maturitas; 2001 Dec; 40(3):229-38. PubMed ID: 11731184
[TBL] [Abstract][Full Text] [Related]
32. Influence of early age at menopause on vertebral bone mass.
Pouillès JM; Trémollières F; Bonneu M; Ribot C
J Bone Miner Res; 1994 Mar; 9(3):311-5. PubMed ID: 8191923
[TBL] [Abstract][Full Text] [Related]
33. Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study.
Gonnelli S; Cepollaro C; Montomoli M; Gennari L; Montagnani A; Palmieri R; Gennari C
Clin Endocrinol (Oxf); 1997 Jan; 46(1):55-61. PubMed ID: 9059558
[TBL] [Abstract][Full Text] [Related]
34. Role of persistent amenorrhea in bone mineral metabolism of young hemodialyzed women.
Weisinger JR; Gonzalez L; Alvarez H; Hernandez E; Carlini RG; Capriles F; Cerviño M; Martinis R; Paz-Martínez V; Bellorín-Font E
Kidney Int; 2000 Jul; 58(1):331-5. PubMed ID: 10886579
[TBL] [Abstract][Full Text] [Related]
35. Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study.
Hassager C; Colwell A; Assiri AM; Eastell R; Russell RG; Christiansen C
Clin Endocrinol (Oxf); 1992 Jul; 37(1):45-50. PubMed ID: 1424192
[TBL] [Abstract][Full Text] [Related]
36. Effect of natural early menopause on bone mineral density.
Francucci CM; Romagni P; Camilletti A; Fiscaletti P; Amoroso L; Cenci G; Morbidelli C; Boscaro M
Maturitas; 2008 Apr; 59(4):323-8. PubMed ID: 18495388
[TBL] [Abstract][Full Text] [Related]
37. Follicle-stimulating hormone and estradiol are associated with bone mineral density and risk of fractures in men with type 2 diabetes mellitus.
Jing Y; Wang X; Yu J; Wang X; Zhou Y; Tao B; Sun L; Liu J; Zhao H
J Diabetes; 2020 Jun; 12(6):426-437. PubMed ID: 31778286
[TBL] [Abstract][Full Text] [Related]
38. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
[TBL] [Abstract][Full Text] [Related]
39. Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation.
Wang J; Zhang W; Yu C; Zhang X; Zhang H; Guan Q; Zhao J; Xu J
PLoS One; 2015; 10(8):e0134986. PubMed ID: 26241313
[TBL] [Abstract][Full Text] [Related]
40. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
